Hawaiʻi’s Medical Cannabis Patients May See Easier Access and Lower Costs as Federal Rule Takes Effect
For years, medical cannabis patients in Hawaiʻi have navigated a complex landscape, with the state allowing its use while the federal government still considers it illegal. However, a recent federal rule change may be bridging this gap. On April 23, the federal government moved certain cannabis products into Schedule III, a significant shift from its previous Schedule I status. This change could lead to easier access, lower costs, and clearer rules for medical cannabis patients in Hawaiʻi, including those who fly between islands with their medication.
However, the new rule also raises questions, particularly for patients who grow their own cannabis at home. Dr. Clifton Otto, a physician and medical cannabis advocate, notes that the rule only applies to medical cannabis produced through licensed state programs, excluding recreational use and home cultivation. This distinction is crucial, as many Hawaiʻi patients legally grow their own cannabis under state law.
“We have a significant number of patients in Hawaiʻi who grow their own cannabis due to the unique growing conditions and their desire for control over their medicine,” Dr. Otto said. “They want to know what’s going into their plants.”
The federal rule change is a step in the right direction for Hawaiʻi’s medical cannabis patients, but it’s essential to address the concerns of patients who grow their own cannabis at home. As the debate around cannabis continues to evolve, patients and advocates alike will be watching to see how this new rule plays out in practice.
